Developing new methods to create natural products for treating diseases
New Methods and Strategies for the Synthesis and Selective Derivatization of Natural Products
This study is exploring new ways to make natural compounds that could help treat health issues like cancer and brain diseases, so patients can have better access to effective medications.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11011377 on NIH RePORTER |
What this research studies
This research focuses on creating innovative techniques to synthesize and modify natural compounds that have potential therapeutic benefits. By improving the availability of cardiotonic steroids and other bioactive molecules, the project aims to enhance treatments for various health conditions, including cancer and neurodegenerative diseases. The research employs advanced catalytic methods to produce these compounds more efficiently, which could lead to new medications. Patients may benefit from improved access to effective treatments derived from these natural products.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from cancer or degenerative neurological disorders who may benefit from novel therapeutic agents.
Not a fit: Patients with conditions unrelated to cancer or neurodegenerative diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatments for cancer and neurodegenerative diseases.
How similar studies have performed: Other research has shown success in developing natural product-based therapies, indicating a promising potential for this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Nagorny, Pavel — University of Michigan at Ann Arbor
- Study coordinator: Nagorny, Pavel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.